AcquisitionOther
Ikena Oncology, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Ikena Oncology, Inc. -> target · $75 million
In our search for the right partner for Ikena, Inmagenes IMG-007 differentiated clinical data in atopic dermatitis and potential as a pipeline in a product across the I&I space was a compelling fit, commented Mark Manfredi, PhD, Chief Executive Officer of I
Open source record (SEC) ↗